Zilvinas Endzinas

Suggest Changes
Learn More
BACKGROUND Dalbavancin, a novel lipoglycopeptide with a pharmacokinetic profile that allows weekly dosing, is active against gram-positive bacteria, including methicillin-resistant Staphylococcus(More)